Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 1;42(3):280-283.
doi: 10.1097/ICO.0000000000003056. Epub 2022 Aug 24.

Ocular Mucus Membrane Pemphigoid: A Primary Versus Secondary Entity

Andrew M Philip  1   2 , Carla C Fernandez-Santos  1   2 , Koosha Ramezani  1   2 , Andrew H Dolinko  1   2 , Ambika Manhapra  1   2 , Sydney Look-Why  1   2 , Peter Y Chang  1   2 , C Stephen Foster  1   2   3 , Stephen D Anesi  1   2
Affiliations
Review

Ocular Mucus Membrane Pemphigoid: A Primary Versus Secondary Entity

Andrew M Philip et al. Cornea. .

Abstract

Purpose: The purpose of this review was to investigate the idea that inflammatory events of the conjunctiva and ocular surface may act as triggering events for the onset of ocular mucus membrane pemphigoid (oMMP).

Methods: A retrospective chart review of patients with biopsy-proven oMMP and no systemic pemphigoid disease. The presence, or absence, of the following inflammatory conditions at the time of OMMP diagnosis was noted: significant eyelid disease, significant atopic eye disease, Stevens-Johnson syndrome, graft-versus-host disease, viral keratitis, sarcoidosis with ocular involvement, chemical burns, medicamentosa, Sjogren syndrome, systemic lupus erythematosus with ocular involvement, and epidemic keratoconjunctivitis. Response to immunomodulatory therapy (IMT) was also recorded.

Results: A total of 779 patient records were identified. Conjunctival biopsy was present in 724 patients, with 646 (89.2%) being positive. One hundred thirty-nine patients (21.5%) with positive biopsies had extraocular pemphigoid disease and were excluded from further analysis. Of the 507 included patients, 154 (30.4%) had at least one of the specified inflammatory conditions present at the time of OMMP diagnosis. One hundred eighteen patients (23.3%) had only 1 such condition, 35 (6.9%) had 2, and 1 patient had 3. In patients with at least one of these conditions present, response to IMT was seen in 84.9% of patients with sufficient follow-up.

Conclusions: Our study suggests that oMMP may arise as a secondary pathology to acute inflammatory events or chronic inflammatory states of the conjunctiva and ocular surface.

PubMed Disclaimer

References

    1. Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527–663.
    1. Kirzhner M, Jakobiec FA. Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol. 2011;26:270–277.
    1. Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370–379.
    1. Nayar M, Wojnarowska F, Venning V, et al. Association of autoimmunity and cicatricial pemphigoid: is there an immunogenetic basis? J Am Acad Dermatol. 1991;25:1011–1015.
    1. Ebrahimiadib N, Hernandez M, Modjtahedi BS, et al. Atopy in patients with ocular cicatricial pemphigoid. Cornea. 2018;37:436–441.

MeSH terms